Various prognostic indicators, including solid malignancies, lymphocytes, lactate dehydrogenase (LDH), C-reactive protein (CRP), platelet, and neutrophil-to-lymphocyte ratio (NLR) have been associated with poor clinical outcomes in non-HIV PJP patients [6–8]. Here, CRP is linked to pneumocystosis.